Evandro de Azambuja, MD, PhD, of the Institut Jules Bordet, Brussels, Belgium, discusses the results of the nationwide study on surgery in de novo metastatic breast cancer (mBC) patients coordinated by the Belgium Cancer Registry (BCR) and the Belgium Society of Medical Oncology (BSMO). This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).